Unknown

Dataset Information

0

Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.

ABSTRACT: Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who received CP, in order to control multiple COVID-19 flares and prolonged SARS-CoV-2 viraemia lasting for 2 months after the initial diagnosis.

SUBMITTER: Karaolidou F 

PROVIDER: S-EPMC8576548 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.

Karaolidou Frini F   Loutsidi Natasa-Eleni NE   Mellios Zois Z   Jahaj Edison E   Eleftheriou Konstantinos K   Pagoni Maria M   Mpaltadakis Ioannis I   Dimopoulos Athanasios-Meletios AM   Kalomenidis Ioannis I   Pappas Apostolos G AG  

Respirology case reports 20211109 12

Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who received CP, in order to control multiple COVID-19 flares and prolonged SARS-CoV-2 viraemia lasting for 2 months after the initial diagnosis. ...[more]

Similar Datasets

Unknown Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.
| S-EPMC7714937 | biostudies-literature
Unknown Convalescent plasma therapy in obese severe COVID-19 adolescents: Two cases report.
| S-EPMC8598255 | biostudies-literature
Unknown A severe refractory COVID-19 patient responding to convalescent plasma; A case series.
| S-EPMC7327024 | biostudies-literature
Unknown Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia
| S-EPMC8907110 | biostudies-literature
Unknown Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency.
| S-EPMC8664001 | biostudies-literature
Unknown Convalescent plasma therapy in patients with COVID-19.
| S-EPMC7676310 | biostudies-literature
Unknown COVID-19 Convalescent Plasma Therapy: Long-term Implications.
| S-EPMC10807994 | biostudies-literature
Unknown COVID-19 convalescent plasma; time for "goal directed therapy"?
| S-EPMC8250757 | biostudies-literature
Unknown COVID-19 convalescent plasma therapy: hit fast, hit hard!
| S-EPMC8251446 | biostudies-literature
Unknown Current Perspectives of convalescent plasma therapy in COVID-19.
| S-EPMC7927533 | biostudies-literature